QuadroPharma has two core business units – Rx (prescription medicine) and consumer health.

This focus is based on the specific, unmet medical need in these therapeutic areas within our region. We develop and implement successful go-to-market strategies for specialty, rare/orphan, hospital and consumer health products.

Premature Ejaculation

PE is a condition characterized by the difficulty or inability to exercise voluntary control over ejaculation and by negative consequence for both suffering men and their partners. Nowadays, a variable number of men suffers from this disease, with an incidence of 1 out of 5 adult men in Europe and higher in other Countries of the World, regardless of age.

Patients suffering from PE are often unwilling to discuss their symptoms and many physicians do not know about effective treatments. As a result, patients may be misdiagnosed or mistreated. Men with PE are more likely to report low satisfaction with their sexual relationship, low satisfaction with sexual intercourse, difficulty relaxing during intercourse, and less frequent intercourse.

Erectile Dysfunction

Differently, ED is defined as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance. Erectile Dysfunction may affect physical and psychosocial health and may have a significant impact on the quality of life (QoL) of sufferers and their partners’.

Erectile Dysfunction shares both unmodifiable and modifiable common risk factors with cardiovascular diseases (e.g., obesity, diabetes mellitus, dyslipidemia, metabolic syndrome, lack of exercise, and smoking).

Epidemiological data reveal that about 152 million men were affected around the world in 1995 and according to estimates, this figure could rise to 322 million by 2025.

North America